Metformin as an adjunct in treatment of Pulmonary Tuberculosis in Non-Diabetic patients.

S. Pothal (Sambalpur (Odisha), India), I. Samantaray (Sambalpur (Odisha), India), S. Biswal (Sambalpur (Odisha), India)

Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Pothal (Sambalpur (Odisha), India), I. Samantaray (Sambalpur (Odisha), India), S. Biswal (Sambalpur (Odisha), India). Metformin as an adjunct in treatment of Pulmonary Tuberculosis in Non-Diabetic patients.. 1601

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Anti-tubercular drug concentrations in Pulmonary Tuberculosis patients - Diabetic vs Non-Diabetic groups.
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019


Epoprostenol dosing by concomitant therapies in the PROSPECT registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Sildenafil in Patients with Severe Group 3 Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

Innovative therapies in Pulmonary Hypertension
Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy
Year: 2016


Pulmonary Hypertension in Hemodialysis Patients
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

Chloroquine as a potential adjunctive therapy in tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014


Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Combination of sPESI and cardiac troponin in the outpatient treatment of pulmoner thromboembolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH).
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Efficacy of moxifloxacin instead of ethambutol in the intensive phase of therapy in newly diagnosed pulmonary TB
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016


Treatment with low-dose everolimus in patients with sporadic lymphangioleiomyomatosis (LAM)
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014

Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2018




Psychiatric Complications in Patients Receiving Treatment for Multi-Drug Resistant Tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


Tuberculosis therapy
Source: International Congress 2016 – Historical landmarks in respiratory medicine: contributions from the UK
Year: 2016


Treatment of Chronic Thromboembolic Pulmonary Hypertension: A new approach
Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension
Year: 2018


Tuberculosis in patients receiving treatment of TNF-alpha inhibitors
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015


Effect of Peri-operative Bronchodilator Therapy on Postoperative Pulmonary Function among Lung Cancer Patients with COPD
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018